TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Angarns Bio AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,559
|
3,131
|
2,511 |
| Financial expenses |
15
|
33
|
21 |
| Earnings before taxes |
1,762
|
2,829
|
2,297 |
| EBITDA |
1,809
|
2,937
|
2,401 |
| Total assets |
21,078
|
20,163
|
17,758 |
| Current assets |
2,529
|
2,646
|
1,180 |
| Current liabilities |
286
|
806
|
1,549 |
| Equity capital |
20,792
|
19,357
|
16,073 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
98.6%
|
96.0%
|
90.5% |
| Turnover per employee |
2,559
|
3,131
|
2,511 |
| Profit as a percentage of turnover |
68.9%
|
90.4%
|
91.5% |
| Return on assets (ROA) |
8.4%
|
14.2%
|
13.1% |
| Current ratio |
884.3%
|
328.3%
|
76.2% |
| Return on equity (ROE) |
8.5%
|
14.6%
|
14.3% |
| Change turnover |
-629
|
442
|
412 |
| Change turnover % |
-20%
|
16%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.